Search
Showing results for "1"
Research
Playgroup participation and social support outcomes for mothers of young children: A longitudinal cohort study.This study aimed to examine friendship networks and social support outcomes for mothers according to patterns of playgroup participation.
Research
Wound healing genes and susceptibility to cutaneous leishmaniasis in BrazilHere we examined single nucleotide polymorphisms (SNPs) in these genes as risk factors for cutaneous (CL) and mucosal leishmaniasis (ML), and leishmaniasis...
Research
Transition to secondary school: Expectation versus experienceThis study investigated what young people in primary school reported being worried about with their impending move to secondary school, and how their...
Research
Is the effect of compulsory community treatmentWe investigated whether a reduction of preventable deaths from physical disorders was mediated by better access to specialized medical procedures.
Research
Chest computed tomography: a validated surrogate endpoint of cystic fibrosis lung disease?Clinical trials for the treatment of cystic fibrosis (CF) lung disease are important to test and optimise new therapeutic interventions.
Research
Evaluating a community-based early childhood education and development program in Indonesia: study protocol for a pragmatic cluster randomized controlled trialThe aim of the trial is to evaluate a community-based early education and development program launched by the Government of Indonesia.
Research
A national prospective surveillance study of acute rheumatic fever in Australian childrenAcute rheumatic fever (ARF) is an important cause of heart disease in Indigenous people of northern and central Australia.
Research
Financial incentives to motivate treatment for hepatitis C with direct acting antivirals among Australian adultsUntreated hepatitis C virus (HCV) infection can result in cirrhosis and hepatocellular cancer. Direct-acting antiviral (DAA) therapies are highly effective and have few side effects compared to older interferon-based therapy. Despite the Australian government providing subsidised and unrestricted access to DAA therapy for chronic HCV infection, uptake has not been sufficient to meet the global target of eliminating HCV as a public health threat by 2030.